public safety · Published brief

FDA recalls heart drug tablets over impurities

The FDA ordered a recall of heart medication tablets because of impurities.

By DoomRadar · Published on DoomRadar Aug 29, 2026, 6:08 PM UTC.

Why it matters

Patients and healthcare providers may need to check affected products and consider treatment alternatives.

Related source links

These links were collected with this event. Recorded source dates may reflect when a link was found. Article publication dates are shown only when available from the source. Open the originals for their full context.

FDA orders recall of heart drug tablets over impurities ↗taipeitimes.com · Recorded source date: Aug 29, 2026, 6:02 PM UTC

AI-assisted, source-based analysis. Methodology · Report a correction

Keep reading

Connected by topic or specific details. Dates below are publication dates; the articles may describe separate events.

Novo Nordisk halts two heart-failure drug trials after earlier late-stage failure

Novo Nordisk stopped two trials of experimental cardiovascular drug ziltivekimab after an independent committee found a low likelihood of success. One heart-attack recovery trial remains active, with results expected in early 2027.

Related details in the reporting
Sep 19, 2026, 5:56 AM UTC